Loading...

A Pilot Pharmacologic Biomarker Study in HLA-Haploidentical Hematopoietic Cell Transplant Recipients

PURPOSE: Eleven patients diagnosed with various hematologic malignancies receiving an HLA-haploidentical hematopoietic cell transplant (HCT) participated in an ancillary biomarker trial. The goal of the trial was to evaluate potential pharmacologic biomarkers pertinent to the conditioning regimen (f...

Full description

Saved in:
Bibliographic Details
Main Authors: Bemer, Meagan J., Sorror, Mohamed, Sandmaier, Brenda M., O’Donnell, Paul V., McCune, Jeannine S.
Format: Artigo
Language:Inglês
Published: 2013
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3786586/
https://ncbi.nlm.nih.gov/pubmed/23907443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2232-8
Tags: Add Tag
No Tags, Be the first to tag this record!